This suggests that when appropriately activated, the upstream Hippo pathway kinases demonstrate tumor suppressor effects, whereas dysregulation within the pathway contributes to oncogenic potential by activation of TAZ and YAP [41]. The gene discussed is YAP1; the disease is neoplasm.